Within experimental models, these compounds are commonly investigated for their interaction with peptide-mediated signalling networks and molecular mechanisms
Changes in skeletal muscle mass have been seen in patients who lose weight with GLP-1RA medications with up to 4.513.2% lean muscle loss or 2050% of the total weight loss [35, 52, 71, 72]
Diabetes 63 , 23322343 (2014)
This third pathway may enhance fat metabolism and energy balance, which is why some people respond differently to retatrutide than to tirzepatide
So, the benefits of reaching a healthy weight arent just physical, although reaching a healthy weight does significantly lower your health risks
Notably, about one in four of these patients did not carry a type 2 diabetes diagnosis , suggesting that a substantial portion of GLP-1 use is being driven by weight loss and other emerging indications outside of diabetes care (Figure 2)